← Back
$DFTX All transactions

Definium Therapeutics, Inc.

A

$ Value

$0

Shares

320,000

Price

$0

Filed

Feb 5

Insider

Name

Barrow Robert

Title

Chief Executive Officer

CIK

0001897557

Roles

Director Officer

Transaction Details

Transaction Date

2026-02-03

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

1,098,477

Footnotes

These shares represent restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one common share of the Issuer. The RSUs vest in 16 equal quarterly installments beginning on June 1, 2026, subject to the Reporting Person providing continuous service to the Issuer on each such vesting date.

Filing Info

Accession No.

0001193125-26-039571

Form Type

4

Issuer CIK

0001813814

Barrow Robert's History

Date Ticker Type Value
2026-03-25 DFTX $451K
2026-02-03 DFTX A $0
2025-12-26 MNMD $339K
2025-09-25 MNMD $252K
2025-06-25 MNMD $180K

Other Insiders at DFTX (90d)

Insider Bought Sold Last
Sullivan Mark
Chief Legal Officer
$198K 2026-03-25
Roberts Brandi
Chief Financial Officer
2026-02-03
Adsett Roger 2026-01-29
Wiley Matthew T.
Chief Commercial Officer
2026-02-03
Barrow Robert
Chief Executive Officer
$451K 2026-03-25
Karlin Daniel
Chief Medical Officer
$148K 2026-03-25